🇺🇸 Nux vomica 30C in United States

10 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

• Window: 22 April 2025 – 22 April 2026
• Total reports: 10

Most-reported reactions

1. Abdominal Discomfort — 1 report (10%)
2. Abnormal Behaviour — 1 report (10%)
3. Arthralgia — 1 report (10%)
4. Burning Sensation — 1 report (10%)
5. Constipation — 1 report (10%)
6. Depression — 1 report (10%)
7. Diarrhoea — 1 report (10%)
8. Discomfort — 1 report (10%)
9. Food Intolerance — 1 report (10%)
10. Gait Inability — 1 report (10%)

Source database →

Frequently asked questions

Is Nux vomica 30C approved in United States?

Nux vomica 30C does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for Nux vomica 30C in United States?

Shaare Zedek Medical Center is the originator. The local marketing authorisation holder may differ — check the official source linked above.